» Authors » Pablo Antonio Urena Torres

Pablo Antonio Urena Torres

Explore the profile of Pablo Antonio Urena Torres including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 34
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Urena Torres P, Pimentel A, Cohen-Solal M
Am J Kidney Dis . 2025 Feb; PMID: 39945703
No abstract available.
2.
Michon-Colin A, Lombardi Y, Seret G, Lavainne F, Testa A, Ayari H, et al.
J Nephrol . 2024 Dec; PMID: 39674977
No abstract available.
3.
Tabibzadeh N, Wang D, Karaboyas A, Schaeffner E, Jacobson S, Vega A, et al.
Clin Kidney J . 2024 Jul; 17(7):sfae141. PMID: 38989279
Background: The use of diuretics in patients on haemodialysis (HD) is thought to maintain diuresis. However, this assumption and the optimal dose are based on little scientific evidence, and associations...
4.
5.
Lionet A, Urena Torres P
Nephrol Ther . 2022 May; 18(3):180-188. PMID: 35514006
Uremic calciphylaxis is a rare disease that affects patients with chronic end-stage renal disease. It is a pathology of the microvessels of the dermis and hypodermis which are calcified and...
6.
Urena Torres P, Souberbielle J, Solal M
Metabolites . 2022 Mar; 12(3). PMID: 35323709
Frequently silent until advanced stages, bone fragility associated with chronic kidney disease-mineral and bone disease (CKD-MBD) is one of the most devastating complications of CKD. Its pathophysiology includes the reduction...
7.
Urena Torres P, Cohen-Solal M
Nephrol Dial Transplant . 2018 Nov; 34(7):1077-1079. PMID: 30403809
No abstract available.
8.
Urena Torres P
Nephrol Ther . 2017 Jun; 13 Suppl 1:S95-S101. PMID: 28577750
Chronic kidney disease is known to be associated with phosphate retention. The mechanisms are complex and the early increase in serum phosphate levels in chronic kidney disease is not strictly...
9.
Urena Torres P, Cohen-Solal M
J Nephrol . 2017 Apr; 30(5):653-661. PMID: 28386879
Chronic kidney disease (CKD) is associated with mineral and bone disorders (MBD) that are now considered as a syndrome. Bone fragility and a four to tenfold increased rate of skeletal...
10.
Negri A, Urena Torres P
Clin Kidney J . 2015 Mar; 8(2):161-7. PMID: 25815172
Increased cardiovascular morbidity and mortality has been associated with the hyperphosphatemia seen in patients with end-stage chronic kidney disease (CKD). Oral phosphate binders are prescribed in these patients to prevent...